Cizzle Biotech tm

HomeTechnology Patents and publicationsPeoplePartners bullet News sectionContacts

 
News

  • Cizzle Biotech Limited Strengthens IP Portfolio with U.S and European Patent Application

    2016 - Cizzle Biotech Limited is pleased to announce granted United States patent application 14/615,045 and European patent application 2316966 relating to Ciz1 blood test for cancer.

  • Telegraph Business Club features Cizzle Biotechnology

The Telegraph Business Club have featured Cizzle on their website with a short film;

Does the secret to early detection of lung cancer lie in a research lab in York? A small yet innovative start up biotechnology company believes its groundbreaking blood test could lead to early diagnosis and help improve treatment outcomes for lung cancer patients.

The founder of Cizzle Biotech explains to the Business Club how the company is rising to the challenges of funding and driving forward research and development with the objective of offering global access to this ingenious yet simple and cost effective test.

Please click below to view the film

http://www.telegraph.co.uk/finance/businessclub/business-club-video/technology-sector-videos/10071683/cizzle-biotechnology.html

  • Cizzle Biotech Limited Strengthens IP Portfolio with Allowance of U.S. Patent Application

York, 25 June 2010 – Cizzle Biotech Limited is pleased to announce the allowance of United States patent application 10/537,228, titled ‘Replication Protein’, by the United States Patent and Trademark Office (USPTO). The allowed claims broadly cover methods of diagnosing cancer by detecting the presence or expression of the Ciz1 gene. Dependent claims cover kits and methods of diagnosing specific cancers including lung cancer.

The allowed patent application is based on the research of the Company’s CSO, Dawn Coverley, PhD. The patent is solely owned by Cizzle. “The patent allowance highlights Cizzle’s position as the foremost leader on Ciz1 and strengthens the Company’s intellectual property portfolio,” said John Lucas, Ph.D., J.D., Chief Executive Officer of Cizzle Biotech Limitd.

  • SCRIP - DRUG MARKET DEVELOPMENTS, Company spotlight: Cizzle Biotech Limited - PDF icondownload

 


Cizzle Biotech Limited
Heslington Hall, Heslington, York, North Yorkshire, Y010 5DD
UK company 5249093

 

graphic